Philip P. Connell to Cyclin-Dependent Kinase Inhibitor p16
This is a "connection" page, showing publications Philip P. Connell has written about Cyclin-Dependent Kinase Inhibitor p16.
Connection Strength
0.187
-
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
Score: 0.187
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.